Results 161 to 170 of about 11,081 (214)

Efficacy of pharmacotherapies on pediatric patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis. [PDF]

BMC Gastroenterol
Yaser S, Yaser H, Mohammed HE, Nasser M, Darwish MK, Haseeb ME, Heiba AH, Ghonaim MM, Aboeldahab H, Bady Z.   +9 more
europepmc   +1 more source

Anti-dengue activity of a cellular lipid uptake inhibitor, lipofermata. [PDF]

Sci Rep
Thongon S, Boonarkart C, Sirihongthong T, Jitobaom K, Punyadee N, Akkarawongsapat R, Avirutnan P, Auewarakul P.   +7 more
europepmc   +1 more source

Anti-Adipogenic Effect of Secondary Metabolites Isolated from <i>Tetracera loureiri</i> on 3T3-L1 Adipocytes. [PDF]

Int J Mol Sci
Lim SH, Park JH, Lee DH, Bang WY, Lee J, Sovann S, Masphal K, Kang JS, Seo DW, Oh JS.   +9 more
europepmc   +1 more source

Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan. [PDF]

J Endocrinol Invest
Tuccinardi D, Masi D, Watanabe M, Zanghi Buffi V, De Domenico F, Berti S, Cipriani V, Manco M, Manfrini S, Pagotto U.   +9 more
europepmc   +1 more source

Orlistat Confers Neuroprotection in Traumatic Brain Injury by Modulating Microglial Lipid Metabolism. [PDF]

Cells
Yu C, Ni Y, Xiong Y, Kang H, Jiang Z, Liu Y, Zhang X, Liu Y, Zhao K, Wang S, Gan C, Zhang H.   +11 more
europepmc   +1 more source

Identification of Potential Pancreatic Lipase Inhibitors from Traditional Chinese Medicines via Molecular Docking, Molecular Dynamics Simulation and In Vitro Validation. [PDF]

Curr Issues Mol Biol
Zhang Z, Long J, Li T, Xu N, Xu Z, Wang Y, Chu M, Zhang M.   +7 more
europepmc   +1 more source

Effects and tolerability of orlistat in the treatment of obesity: a 6 mth dose-ranging study

, 1998
Van Gaal, Luc, Toplak, H., Broom, J., Enzi, G.   +3 more
core  

Economic Evaluation of Medications in Prevention and Treatment of Obesity: A Systematic Review. [PDF]

Int J Prev Med
Afshari S, Khosravi M, Zamandi M, Rezapour A, Hadian M, Souresrafil A, Mazaheri E, Gallehzan NA.   +7 more
europepmc   +1 more source

Synthetic pancreatic lipase inhibitors in obesity treatment: current updates on <i>in silico</i> design, synthesis, bioactivity, and SAR. [PDF]

RSC Med Chem
Jagtap UA, Paul AT.
europepmc   +1 more source

Anti-Obesity, Lipid-Lowering, and Anti-Hyperglycemic Effects of CB-02 in High-Fat-Diet-Induced Obese Mice. [PDF]

Molecules
Hiep HL, Bang PV, Nhan ND, Ngan NH, To DC, Dung NV, Phu LH.   +6 more
europepmc   +1 more source